Research
Latest published research we're tracking.
The newest skincare and haircare papers from PubMed, linked to the ingredients we decode. Summaries are the authors' own abstracts — we excerpt, attribute, and link out to the source.
5 papers under Scalp & dandruff
Pediculosis capitis: a hidden threat in tropical regions.
Clinical and experimental dermatology · 2026
Pediculosis capitis, caused by Pediculus humanus var. capitis, is a common ectoparasitic infestation primarily affecting school-aged children worldwide. It is transmitted through direct head-to-head contact and occasionally via fomites. Although it is not a vector for diseases, it causes significant psychosocial and economic burdens, including scalp itching, parental anxiety, absenteeism and… Read on PubMed →
Efficacy of shortwave radiofrequency-assisted delivery of Quhong Zhiyang ointment in the treatment of facial seborrheic dermatitis: a retrospective study of 72 patients.
Cutaneous and ocular toxicology · 2026
OBJECTIVE: To observe the clinical efficacy of Quhong Zhiyang ointment via shortwave radiofrequency-assisted delivery in the treatment of facial seborrheic dermatitis. METHODS: Seventy-two individuals who were diagnosed with seborrheic dermatitis and who received treatment and completed a 3-month follow-up period were enrolled in this retrospective analysis, with 36 patients in each group. The… Read on PubMed →
T Cell Immunosenescence in Inflammatory Skin Diseases: Pathogenesis and Therapeutic Targets.
Aging cell · 2026
T cell immunosenescence refers to the progressive functional decline of T lymphocytes with aging, characterized by the phenotypic markers, mitochondrial dysfunction, and the senescence-associated secretory phenotype (SASP), representing a pivotal aspect of overall immune aging. This review systematically elucidates the critical role of T cell immunosenescence in the pathogenesis of common… Read on PubMed →
Practical considerations for managing patients being treated with topical roflumilast.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
Topical roflumilast, available in 0.3% cream, 0.15% cream, and 0.3% foam formulations, is a novel, highly potent phosphodiesterase-4 (PDE4) inhibitor that was recently approved in Canada for the treatment of plaque psoriasis, atopic dermatitis, and seborrheic dermatitis, respectively. Topical formulations were shown in clinical trials to significantly improve disease symptoms with excellent… Read on PubMed →
Atopic dermatitis reconsidered: Clinical mimics and diagnostic pearls.
Journal of the American Academy of Dermatology · 2026
Atopic dermatitis (AD) is a chronic, pruritic inflammatory skin condition with a complex pathogenesis and variable clinical presentation, often overlapping with other dermatologic diseases. This article considers the differential diagnoses for AD, emphasizing the importance of accurately distinguishing it from both common and rare conditions. Among inflammatory dermatoses, seborrheic dermatitis… Read on PubMed →